Nkarta to host conference call to discuss updated NKX101 clinical data on June 27

Nkarta, Inc.

Press release on June 26, 2023 announces conference call for June 27, 2023 at 8:00 a.m. ET.
Call to review updated clinical data from ongoing trial of NKX101, an allogeneic CAR NK cell therapy targeting NKG2D ligands.
Company ticker NKTX; slides will be available on Nkarta's website.
Replay of call archived for approximately four weeks.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.